Debio-025: Phase Ib data

In a 15-day, double-blind, placebo-controlled Phase Ib trial in 23 treatment-naïve HIV/HCV co-infected patients, twice-daily

Read the full 154 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE